Optimisation of oligonucleotide separations using YMC´s non porous anion exchanger BioPro IEX QF
contributed by YMC |
Nucleic acid therapeutics such as antisense, siRNA and aptamers are expected to play an important role as the next-generation pharmaceuticals together with antibody drugs. These drugs demand chromatographic purification and analysis that can recognize slight structural differences following synthesis. In this report, useful tips for optimisation of ion exchange chromatography methods for oligonucleotides are provided.
Read the full article now
Log in or register to read this article in full and gain access to The Analytical Scientist’s entire content archive. It’s FREE and always will be!
Login
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Analytical Scientist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.
